ABL1 and lung cancer: Tumors treated with vehicle control existed in a dedifferentiated, mesenchymal state, and upon treatment with the ABL allosteric inhibitor GNF-5, the lung cancer cells underwent differentiation into an epithelial-like state making the tumors more susceptible to docetaxel.